Tag Archives: NI

recommended stocks to buy today

Maybe the election is over and maybe we all have to get back to work. What is not over is that the current Powerball jackpot has reached a massive $320 million. Maybe this is a lower amount at $202 million for the cash value lump-sum payment, but either way it is empire making money that can create multi-generational wealth.

With the drawing set for Saturday, November 19, the reality is that....More>>>

Top 10 Low Price Stocks To Invest In 2018

A few days ago, an article about Nike (NYSE:NKE) argued that “Nike’s shares aren’t priced to buy.” The reasoning was that “Nike is, at best, fairly valued. And it certainly isn’t trading hands at fire-sale prices.” The question is: should you expect (and wait for) fire-sales prices? Most value investors know the maxim that it is better to buy a great business....More>>>

top shares

Winter Park, FL, based Investment company Deprince Race & Zollo Inc buys General Electric Co, Retail Opportunity Investments Corp, Umpqua Holdings Corp, Ferroglobe PLC, Cabot Corp, Nucor Corp, B&G Foods Inc, Cisco Systems Inc, Outfront Media Inc, Commercial Metals Co, sells Terex Corp, WestRock Co, Rockwell Automation Inc, Apple Inc, Adtran Inc during the 3-months ended 2017-06-30, according....More>>>

Top 10 Medical Stocks To Buy Right Now

Inovalon (NASDAQ: INOV) sells its cloud based health care data to health plans and pharmaceutical companies across the United States. The company has data on 139 million members (~42% of the U.S. population) and has data on nearly 12 billion medical events covering nearly 99% of U.S. counties. Inovalon is Samadhi Partners #1 M&A target for 2017.

Inovalon’s client base includes 76%....More>>>

the best shares

Since coming to the public markets in early 2013, Stemline Therapeutics (NASDAQ:STML) shareholders have experienced one heck of a ride.

Source: BigCharts.com

The share price reached $47 on positive news for its leading drug candidate SL-401, with Roth Capital setting a $50 price target, Jefferies a $60 price target, Aegis a whopping $70 price target. Reasons for enthusiasm included....More>>>